Donatussin Interactions
There are 417 drugs known to interact with Donatussin (chlophedianol/guaifenesin/phenylephrine), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 29 are major, 387 are moderate, and 1 is minor.
- View all 417 medications that may interact with Donatussin
- View Donatussin alcohol/food interactions (1)
- View Donatussin disease interactions (4)
Most frequently checked interactions
View interaction reports for Donatussin (chlophedianol / guaifenesin / phenylephrine) and the medicines listed below.
- acetaminophen
- Advair Diskus (fluticasone / salmeterol)
- albuterol
- alprazolam
- amoxicillin / clavulanate
- Amoxil (amoxicillin)
- Anaprox (naproxen)
- atorvastatin
- Azithromycin Dose Pack (azithromycin)
- cetirizine
- chondroitin / glucosamine
- Combivent (albuterol / ipratropium)
- Crestor (rosuvastatin)
- cyclobenzaprine
- Cytomel (liothyronine)
- dexamethasone
- diclofenac
- Doculax (docusate/senna)
- docusate
- doxycycline
- estradiol topical
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flonase (fluticasone nasal)
- fluoxetine
- ibuprofen
- ketorolac
- Levaquin (levofloxacin)
- loratadine
- Medent-DMI (dextromethorphan / guaifenesin / pseudoephedrine)
- Spiriva (tiotropium)
Donatussin alcohol/food interactions
There is 1 alcohol/food interaction with Donatussin (chlophedianol / guaifenesin / phenylephrine).
Donatussin disease interactions
There are 4 disease interactions with Donatussin (chlophedianol / guaifenesin / phenylephrine) which include:
More about Donatussin (chlophedianol / guaifenesin / phenylephrine)
- Donatussin consumer information
- Compare alternatives
- Side effects
- Dosage information
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.